Robert Kushner

In this engaging discussion, obesity expert Robert Kushner, a Professor at Northwestern University, delves into the challenges of managing adverse effects of obesity medications like semaglutide and tirzepatide. He explores gastrointestinal side effects such as nausea and diarrhea, offering practical strategies for dietary management. Kushner also emphasizes the importance of addressing hydration and dosage adjustments, while highlighting how resistance training and high-protein diets can protect muscle health during treatment. A must-listen for anyone navigating the world of obesity therapies!

Robert Kushner, a renowned author and professor at Northwestern University's Feinberg School of Medicine, dives into the latest advancements in obesity treatment. He discusses new FDA-approved medications, such as semaglutide and terzepatide, highlighting their effectiveness and side effects. Kushner emphasizes the importance of treating obesity as a chronic disease, the potential implications of stopping medication, and the need for gradual dose adjustments. This insightful conversation sheds light on the evolving landscape of obesity management.

Dr. Deborah Horn and Dr. Robert Kushner discuss challenges and solutions in obesity management with Dr. Neil Skolnik. They cover topics such as tailored care, pharmacotherapy, muscle loss prevention, body composition in older adults, weight management for diabetic patients, and the collaborative approach to treating obesity in primary care.